ORCHID MEDICINE LTD

Company Registration Number:
13391269 (England and Wales)

Unaudited abridged accounts for the year ended 31 October 2024

Period of accounts

Start date: 01 November 2023

End date: 31 October 2024

ORCHID MEDICINE LTD

Contents of the Financial Statements

for the Period Ended 31 October 2024

Company Information - 3
Balance sheet - 4
Additional notes - 6
Balance sheet notes - 9

ORCHID MEDICINE LTD

Company Information

for the Period Ended 31 October 2024




Director: Rishma Gohil
Registered office: 4
Park Avenue
Radlett
England
WD7 7EA
Company Registration Number: 13391269 (England and Wales)

ORCHID MEDICINE LTD

Balance sheet

As at 31 October 2024


Notes

2024
£

2023
£
Fixed assets
Tangible assets: 4 1,465 1,954
Total fixed assets: 1,465 1,954
Current assets
Debtors: 54,898
Cash at bank and in hand: 11,486 102,718
Total current assets: 66,384 102,718
Creditors: amounts falling due within one year: ( 21,467 )
Net current assets (liabilities): 66,384 81,251
Total assets less current liabilities: 67,849 83,205
Total net assets (liabilities): 67,849 83,205

The notes form part of these financial statements

ORCHID MEDICINE LTD

Balance sheet continued

As at 31 October 2024


Notes

2024
£

2023
£
Capital and reserves
Called up share capital: 1 1
Profit and loss account: 67,848 83,204
Shareholders funds: 67,849 83,205

For the year ending 31 October 2024 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

The members have agreed to the preparation of abridged accounts for this accounting period in accordance with Section 444(2A).

These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

This report was approved by the board of directors on 18 July 2025
And Signed On Behalf Of The Board By:

Name: Rishma Gohil
Status: Director

The notes form part of these financial statements

ORCHID MEDICINE LTD

Notes to the Financial Statements

for the Period Ended 31 October 2024

  • 1. Accounting policies

    Basis of measurement and preparation

    These financial statements have been prepared in accordance with the provisions of Section 1A (Small Entities) of Financial Reporting Standard 102

ORCHID MEDICINE LTD

Notes to the Financial Statements

for the Period Ended 31 October 2024

  • 2. Employees


    2024

    2023
    Average number of employees during the period 2 1

ORCHID MEDICINE LTD

Notes to the Financial Statements

for the Period Ended 31 October 2024

  • 3. Off balance sheet disclosure

    No

ORCHID MEDICINE LTD

Notes to the Financial Statements

for the Period Ended 31 October 2024

4. Tangible Assets

Total
Cost £
At 01 November 2023 3,475
Additions -
Disposals -
Revaluations -
Transfers -
At 31 October 2024 3,475
Depreciation
At 01 November 2023 1,521
Charge for year 489
On disposals -
Other adjustments -
At 31 October 2024 2,010
Net book value
At 31 October 2024 1,465
At 31 October 2023 1,954